603127: Joinn Laboratories(China)Co.,Ltd. - Summary | Jitta

Joinn Laboratories(China)Co.,Ltd.

CHN:603127

Price
CN¥35.17
Loss Chance
50.8%
3.03JITTA SCORE
> 1,000%Over Jitta Line
Jitta Ranking
428 / 486
4,415 / 5,261
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (15)
Recent Business Performance (22)
Financial Strength (82)
Return to Shareholders (32)
Competitive Advantage (24)
Jitta Signs
Debt LevelLow Long Term Debt
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 202.28% in the last quarter (yoy)
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
3.03
> 1,000%
4.23
> 1,000%
Life Sciences Tools and Services
4.93
> 1,000%
6.36
20.25%
6.58
233.76%
COMPANY DESCRIPTION
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment engages in the design, production, breeding, and sale of research models, including non-human primates and rodents. The company also offers cell-based assay (CBA) services. In addition, it offers drug quality research and testing services for protein drugs, vaccines, gene and cell therapy products, and provides customized solutions for early-stage drug discovery, screening, and mechanism research. Joinn Laboratories(China)Co.,Ltd. was incorporated in 1995 and is headquartered in Beijing, China.